Related Experiment Videos

pH-dependent aggregation and secretion of soluble monomeric influenza hemagglutinin

P Vanlandschoot1, E Beirnaert, J Grooten

  • 1Laboratory of Molecular Biology, Flanders Interuniversity Institute of Biotechnology, University of Ghent, Belgium.

Archives of Virology
|April 29, 1998
PubMed

Insights

Researchers found that soluble hemagglutinin (HA) from A/Victoria/3/75 (H3N2) exists in monomeric and trimeric forms in cell culture supernatant. Aggregation into larger structures is linked to low intracellular pH during secretion.

Area of Science:

  • Virology
  • Protein Biochemistry
  • Cell Biology

Background:

  • Previous work reported expression of soluble A/Victoria/3/75 (H3N2) hemagglutinin (HA) in insect cells.
  • An aggregated HA fraction was observed in cell supernatant specifically at low pH during expression.

Purpose of the Study:

  • To investigate the different structural forms of soluble H3N2 hemagglutinin in cell supernatant.
  • To determine the factors influencing the formation of aggregated HA structures.

Main Methods:

  • Expression of soluble A/Victoria/3/75 (H3N2) hemagglutinin in insect cells.
  • Analysis of cell supernatant using biochemical and biophysical techniques to identify different HA structures.
  • Investigation of the role of pH in HA aggregation during secretion.

Main Results:

  • Monomeric and possibly trimeric forms of soluble H3N2 hemagglutinin are detected in cell supernatant.
  • These monomeric and trimeric structures are present irrespective of the culture medium pH.
  • Evidence suggests that the aggregated HA fraction arises from monomeric HA molecules due to low intracellular pH during secretion.

Conclusions:

  • Soluble H3N2 hemagglutinin exists in multiple structural forms (monomeric, trimeric, aggregated) in the cell supernatant.
  • Intracellular pH is a critical factor controlling the aggregation state of secreted H3N2 hemagglutinin.
  • Understanding these structural variations is important for influenza virus research and vaccine development.

Related Concept Videos